Susan Hall Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Susan Hall.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Susan Hall. Susan Hall is Global Head of R&D in Valeant Pharmaceuticals International, Inc. ($BVF) and EVP, CSO, Global Head of R&D in Endo International plc ($ENDP).
Latest Insider Trading Transactions of Susan Hall
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 14 2016 | ENDP | Endo International ... | Hall Susan | EVP, CSO, Global He ... | Payment of Exercise | F | 41.67 | 626 | 26,085 | 4,826 | 5.5 K to 4.8 K (-11.48 %) |
| Feb 25 2016 | ENDP | Endo International ... | Hall Susan | EVP, CSO, Global He ... | Option Exercise | A | 50.22 | 22,481 | 1,128,996 | 22,481 | |
| Feb 25 2016 | ENDP | Endo International ... | Hall Susan | EVP, CSO, Global He ... | Payment of Exercise | F | 49.85 | 239 | 11,914 | 3,160 | 3.4 K to 3.2 K (-7.03 %) |
| Feb 25 2016 | ENDP | Endo International ... | Hall Susan | EVP, CSO, Global He ... | Grant | A | 0.00 | 6,665 | 0 | 14,180 | 7.5 K to 14.2 K (+88.69 %) |
| Feb 25 2016 | ENDP | Endo International ... | Hall Susan | EVP, CSO, Global He ... | Grant | A | 0.00 | 13,331 | 0 | 27,071 | 13.7 K to 27.1 K (+97.02 %) |
| Nov 12 2015 | ENDP | Endo International ... | Hall Susan | EVP, CSO, Global He ... | Grant | A | 0.00 | 1,000 | 0 | 13,740 | 12.7 K to 13.7 K (+7.85 %) |
| Nov 12 2015 | ENDP | Endo International ... | Hall Susan | EVP, CSO, Global He ... | Buy | P | 55.35 | 1,000 | 55,350 | 2,666 | 1.7 K to 2.7 K (+60.02 %) |
| Mar 13 2015 | ENDP | Endo International ... | Hall Susan | EVP, CSO, Global He ... | Payment of Exercise | F | 89.44 | 626 | 55,989 | 1,666 | 2.3 K to 1.7 K (-27.31 %) |
| Feb 26 2015 | ENDP | Endo International ... | Hall Susan | EVP, CSO, Global He ... | Option Exercise | A | 85.25 | 10,823 | 922,661 | 10,823 | |
| Feb 26 2015 | ENDP | Endo International ... | Hall Susan | EVP, CSO, Global He ... | Grant | A | 0.00 | 2,932 | 0 | 9,807 | 6.9 K to 9.8 K (+42.65 %) |
| Feb 26 2015 | ENDP | Endo International ... | Hall Susan | EVP, CSO, Global He ... | Grant | A | 0.00 | 5,865 | 0 | 12,740 | 6.9 K to 12.7 K (+85.31 %) |
| Mar 08 2012 | BVF | Valeant Pharmaceut ... | Hall Susan | Global Head of R&D | Option Exercise | M | 13.24 | 16,120 | 213,429 | 32,240 | |
| Mar 08 2012 | BVF | Valeant Pharmaceut ... | Hall Susan | Global Head of R&D | Sell | S | 54.50 | 16,120 | 878,513 | 0 | 16.1 K to 0 (-100.00 %) |
| Mar 08 2012 | BVF | Valeant Pharmaceut ... | Hall Susan | Global Head of R&D | Grant | A | 13.24 | 16,120 | 213,429 | 16,120 | 0 to 16.1 K |
Page: 1